Street Calls of the Week
This article summarizes the most significant insider buys and sells reported for US stocks on Thursday, October 9, 2025.
Top Insider Buys:
• Angiodynamics Inc (NASDAQ:ANGO): James C. Clemmer, President and CEO of Angiodynamics Inc, acquired 10,000 shares of common stock on October 9, 2025. The shares were purchased at a weighted average price of $11.15, in multiple transactions ranging from $11.10 to $11.17, for a total transaction value of $111,500. Following the purchase, Clemmer directly owns 882,529 shares of Angiodynamics. The medical device company, currently valued at $459 million, has seen its stock surge 81% over the past year.
• aTyr Pharma Inc (NASDAQ:ATYR): Director Paul Schimmel of aTyr Pharma Inc, currently valued at $93.77 million, purchased a total of 1,000,000 shares of the company’s common stock. On October 8, 2025, Schimmel acquired 682,001 shares at a weighted average price of $0.898, with prices ranging from $0.8536 to $0.95 per share. The following day, October 9, 2025, he bought an additional 317,999 shares at a weighted average price of $0.9414, with prices ranging from $0.93 to $0.95 per share. The total transaction value amounted to $911,801.
• Zenas BioPharma, Inc. (NASDAQ:ZBIO): Director Leon O. Moulder Jr. of Zenas BioPharma, Inc. acquired 36,928 shares of common stock on October 7, 2025, at a price of $20.85 per share, for a total transaction value of $769,948. The purchase was made by The Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008, of which Moulder is a Trustee. Following the transaction, the trust directly holds 36,928 shares. Moulder also indirectly holds 1,672,039 shares through Tellus BioVentures LLC and directly holds 266,155 shares.
• Agree Realty (NYSE:ADC): Director John Rakolta Jr. purchased 25,154 common shares of Agree Realty on October 7, 2025. The shares were bought at a price of $70.41, for a total transaction value of $1.77 million. The prices paid for the shares ranged from $70.30 to $70.50. Following the transaction, Rakolta directly owns 553,700.498 shares of Agree Realty.
• Zenas BioPharma Inc (NASDAQ:ZBIO): Director Lu Hongbo reported purchasing shares of Zenas BioPharma Inc in two transactions, totaling $6,000,031. On September 13, 2024, Lu acquired 58,823 shares at $17.0 per share. Subsequently, on October 7, 2025, Lu Hongbo bought 263,160 shares at $19.0 each. The stock is currently trading at $27.78, having seen remarkable growth with a 216% gain year-to-date.
Top Insider Sells:
• Cloudflare, Inc. (NASDAQ:NET): Michelle Zatlyn, President and Board Co-Chair at Cloudflare, Inc., sold a total of 77,818 shares of Class A Common Stock between October 7 and October 9, 2025. The sales were executed at prices ranging from $214.8634 to $220.9941, netting Zatlyn approximately $16.7 million. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 14, 2025.
• Samsara Inc (NYSE:IOT): Director John Bicket of Samsara Inc sold a total of 166,145 shares of Class A Common Stock on October 7, 2025, in a series of transactions. The sales, executed under two separate Rule 10b5-1 trading plans, totaled approximately $6.5 million. Under the first trading plan, Bicket sold 137,800 shares at prices ranging from $37.26 to $40.37, for a total value of $5,240,207.
• Samsara Inc. (NYSE:IOT): Sanjit Biswas, Chief Executive Officer of Samsara Inc., sold shares of the company’s Class A Common Stock on October 7, 2025, for a total of approximately $6.1 million. The sales were executed in a series of transactions with prices ranging from $37.7749 to $40.311 per share. Biswas sold 127,711 shares for approximately $4,857,575.
• NuScale Power Corp (NASDAQ:SMR): Fluor Corp sold 909,551 shares of NuScale Power Corp on October 7th and 8th, 2025. The shares were sold in multiple transactions with prices ranging from $39.42 to $43.13, netting a total of $36,868,176.
• Eli Lilly & Co (NYSE:LLY): Lilly Endowment Inc, a ten percent owner in Eli Lilly & Co, has sold 85,810 shares of common stock on October 8, 2025. The sales, executed in multiple transactions, fetched a total of $86,234,873 with prices ranging from $848.46 to $856.0.
Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance. However, it’s important to consider these transactions in the context of broader market trends and company-specific factors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.